Clinical and Radiograhic Evaluation of NIPSA With and Without Allograft Plus Platelet Rich Fibrin in the Treatment of Intraosseous Defects in Stage III Periodontitis Patients

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04444063
Collaborator
(none)
24
2
37

Study Details

Study Description

Brief Summary

Several minimal invasive techniques have been proposed since the last decade aiming to enhance and provide adequate environment for periodontal regeneration. Harrel and Rees proposed minimally invasive surgery (MIS) in 1995 and minimal invasive surgical technique (MIST) that was introduced in 2007 and then further enforced with modified minimally invasive surgical technique (M-MIST) in 2009 . A new minimal invasive technique called Non-Incised Papilla Surgical Approach (NIPSA) was introduced in 2017. It is aims to maintain the marginal tissues integrity by placing horizontal or oblique incision apical to the defect approaching the defect through apical access.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-Incised Papilla Surgical Approach
N/A

Detailed Description

Intraosseous vertical defects are one of the consequences that could result from periodontitis, which are classified according to their architecture by the number of residual walls, defect width as well as topographic extension in relation to the tooth.

Conventional surgery done for regenerative purpose regarding vertical defects has been known to be affected by clot stability, it was reported in the literature that reduced clinical outcomes occurred when early wound failure and exposure of the treated area occurred. This led to the innovation of different minimally invasive flap techniques that aimed at reducing the surgical trauma, allowing blood clot stability, protecting the regenerating site, reducing patient discomfort postoperatively as well as minimizing surgical chair time Among these techniques are papilla preservation flaps and minimally invasive surgical approaches with papilla elevation or without papilla elevation . However, these techniques had in their design incisions related to the interdental papilla which would jeopardize and complicate the vascular integrity of the interdental tissues Non incised Papilla surgical approach is a new surgical technique introduced by Moreno Rodriguez in 2017 to maintain the marginal tissues and the papilla intact by placing a horizontal or oblique incision apical to the defect and approaching it through an apical access leaving the marginal tissues to act as a "dome " protecting the blood clot

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
it is a Randomized clinical trialit is a Randomized clinical trial
Masking:
Single (Outcomes Assessor)
Masking Description:
single blinded
Primary Purpose:
Treatment
Official Title:
Clinical and Radiographic Evaluation of the Non-Incised Papilla Surgical Approach With and Without Allograft Plus Platelet Rich Fibrin in Treatment of Intraosseous Defects in Stage III Periodontitis Patients: A Randomized-Controlled Clinical Trial
Anticipated Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: NIPSA technique with Allograft plus PRF

Non-incised papilla preservation technique to treat intraosseous bony defects with the addition of Allograft plus PRF

Procedure: Non-Incised Papilla Surgical Approach
Horizontal or oblique incision is done on the buccal mucosa as far as possible from the marginal keratinized tissue and the inter dental papilla The horizontal/oblique incision is extended mesio-distally enough to allow proper visualization of the defect A full thickness flap is elevated apico- coronally to expose the coronal limit of the defect Scaling and root planning are done using mini-curettes and power driven ultrasonic tips with care trying to maintain fibers attached to the cementum Granulation tissue is removed with mini-curettes detached from the bony walls and removed from the base of the papilla carefully with microblades and microscissors . 1ry soft tissue closure will be performed by horizontal mattress suture 2mm from the edges of the incision as a first line of closure and then simple interrupted suture as a second line of closure using (5-0, 6-0) polypropylene suture.

Active Comparator: NIPSA technique

Non-incised papilla preservation technique to treat intraosseous bony defects without the addition of Allograft plus PRF

Procedure: Non-Incised Papilla Surgical Approach
Horizontal or oblique incision is done on the buccal mucosa as far as possible from the marginal keratinized tissue and the inter dental papilla The horizontal/oblique incision is extended mesio-distally enough to allow proper visualization of the defect A full thickness flap is elevated apico- coronally to expose the coronal limit of the defect Scaling and root planning are done using mini-curettes and power driven ultrasonic tips with care trying to maintain fibers attached to the cementum Granulation tissue is removed with mini-curettes detached from the bony walls and removed from the base of the papilla carefully with microblades and microscissors . 1ry soft tissue closure will be performed by horizontal mattress suture 2mm from the edges of the incision as a first line of closure and then simple interrupted suture as a second line of closure using (5-0, 6-0) polypropylene suture.

Outcome Measures

Primary Outcome Measures

  1. Clinical attachment level gain (CAL) clinical attachment level gain (CAL) [12 months]

    measured with UNC periodontal probe in mm

Secondary Outcome Measures

  1. Gingival recession (GR) [12 months]

    measured with UNC periodontal probe in mm

  2. Pocket depth (PD) [12 months]

    measured with UNC periodontal probe in mm

  3. Radiographic defect fill [12 months]

    standardized digital periapical radiograph

  4. Gingival bleeding [T1 T2 (Surgical phase- 8 weeks) , T4 3- months post-surgical ,T5 6-months post-surgical ,T6 1- Year post-surgical]

    Gingival bleeding score

  5. Plaque index [12 months]

    Plaque Index score

  6. Post-surgical patient Satisfaction [12 months]

    (1-7) point scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with Stage III periodontitis patient having at least one tooth with two wall or combined two to three walled intraosseous defect more than or equal 3 mm deep (assessed by trans-gingival probing, radiographic examination) with clinical attachment level (CAL) more than or equal 5mm and pocket depth (PD) more than or equal 6 mm.

  • Defect not extending to a root furcation area.

  • Vital teeth

  • No history of intake of antibiotics or other medications affecting the periodontium in the previous 6 months.

  • No surgical periodontal therapy carried out in the past 6 months.

  • Able to sign an informed consent form.

  • Patients who are cooperative, motivated, and hygiene conscious.

  • Able to come for the follow up appointment's needed.

Exclusion Criteria:
  • Any systemic disease that contra-indicates periodontal surgery or may affect healing.

  • Smokers

  • Pregnant females

  • Drug abusers

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Chair: Omneya Abo-Eldahab, PHD, Cairo University
  • Study Chair: Omneya K. Tawfeek, PHD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ahmed mohamed Ibrahim Elkady, Teaching Assistant, Cairo University
ClinicalTrials.gov Identifier:
NCT04444063
Other Study ID Numbers:
  • PER 3-3-3
First Posted:
Jun 23, 2020
Last Update Posted:
Jun 23, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ahmed mohamed Ibrahim Elkady, Teaching Assistant, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2020